These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 33964945)

  • 1. Longitudinal study based on a safety registry for malaria patients treated with artenimol-piperaquine in six European countries.
    Vignier N; Bouchaud O; Angheben A; Bottieau E; Calleri G; Salas-Coronas J; Martin C; Ramos JM; Mechain M; Rapp C; Nothdurft HD; Velasco M; Bardají A; Rojo-Marcos G; Visser LG; Hatz C; Bisoffi Z; Jelinek T; Duparc S; Bourhis Y; Tommasini S; Iannucelli M; Bacchieri A; Mattera GG; Merlo Pich E; Behrens RH
    Malar J; 2021 May; 20(1):214. PubMed ID: 33964945
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prospective observational study to evaluate the clinical safety of the fixed-dose artemisinin-based combination Eurartesim® (dihydroartemisinin/piperaquine), in public health facilities in Burkina Faso, Mozambique, Ghana, and Tanzania.
    Baiden R; Oduro A; Halidou T; Gyapong M; Sie A; Macete E; Abdulla S; Owusu-Agyei S; Mulokozi A; Adjei A; Sevene E; Compaoré G; Valea I; Osei I; Yawson A; Adjuik M; Akparibo R; Ogutu B; Upunda GL; Smith P; Binka F
    Malar J; 2015 Apr; 14():160. PubMed ID: 25885858
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pyronaridine-artesunate or dihydroartemisinin-piperaquine versus current first-line therapies for repeated treatment of uncomplicated malaria: a randomised, multicentre, open-label, longitudinal, controlled, phase 3b/4 trial.
    West African Network for Clinical Trials of Antimalarial Drugs (WANECAM)
    Lancet; 2018 Apr; 391(10128):1378-1390. PubMed ID: 29606364
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Artenimol-piperaquine in children with uncomplicated imported falciparum malaria: experience from a prospective cohort.
    Pull L; Lupoglazoff JM; Beardmore M; Michel JF; Buffet P; Bouchaud O; Siriez JY
    Malar J; 2019 Dec; 18(1):419. PubMed ID: 31843017
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Electrocardiographic Safety of Repeated Monthly Dihydroartemisinin-Piperaquine as a Candidate for Mass Drug Administration.
    Millat-Martínez P; Ila R; Laman M; Robinson L; Karunajeewa H; Abel H; Pulai K; Sanz S; Manning L; Moore B; Bassat Q; Mitjà O
    Antimicrob Agents Chemother; 2018 Dec; 62(12):. PubMed ID: 30249696
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multi-Country Evaluation of Safety of Dihydroartemisinin/Piperaquine Post-Licensure in African Public Hospitals with Electrocardiograms.
    Kabanywanyi AM; Baiden R; Ali AM; Mahende MK; Ogutu BR; Oduro A; Tinto H; Gyapong M; Sie A; Sevene E; Macete E; Owusu-Agyei S; Adjei A; Compaoré G; Valea I; Osei I; Yawson A; Adjuik M; Akparibo R; Kakolwa MA; Abdulla S; Binka F
    PLoS One; 2016; 11(10):e0164851. PubMed ID: 27764178
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Electrocardiographic safety evaluation of extended artemether-lumefantrine treatment in patients with uncomplicated Plasmodium falciparum malaria in Bagamoyo District, Tanzania.
    Mhamilawa LE; Wikström S; Mmbando BP; Ngasala B; Mårtensson A
    Malar J; 2020 Jul; 19(1):250. PubMed ID: 32664948
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Randomized, double-blind, placebo-controlled clinical trial of a two-day regimen of dihydroartemisinin-piperaquine for malaria prevention halted for concern over prolonged corrected QT interval.
    Manning J; Vanachayangkul P; Lon C; Spring M; So M; Sea D; Se Y; Somethy S; Phann ST; Chann S; Sriwichai S; Buathong N; Kuntawunginn W; Mitprasat M; Siripokasupkul R; Teja-Isavadharm P; Soh E; Timmermans A; Lanteri C; Kaewkungwal J; Auayporn M; Tang D; Chour CM; Prom S; Haigney M; Cantilena L; Saunders D
    Antimicrob Agents Chemother; 2014 Oct; 58(10):6056-67. PubMed ID: 25092702
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Electrocardiographic effect of artemisinin-piperaquine, dihydroartemisinin-piperaquine, and artemether-lumefantrine treatment in falciparum malaria patients.
    Wu W; Lu C; Liang Y; Zhang H; Deng C; Wang Q; Xu Q; Tan B; Zhou C; Song J
    Rev Soc Bras Med Trop; 2021; 54():e05362020. PubMed ID: 33605379
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Post-licensure safety evaluation of dihydroartemisinin piperaquine in the three major ecological zones across Ghana.
    Oduro AR; Owusu-Agyei S; Gyapong M; Osei I; Adjei A; Yawson A; Sobe E; Baiden R; Adjuik M; Binka F
    PLoS One; 2017; 12(3):e0174503. PubMed ID: 28358871
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dihydroartemisinin-piperaquine treatment failure in uncomplicated Plasmodium falciparum malaria case imported from Ethiopia.
    Russo G; L'Episcopia M; Menegon M; Souza SS; Dongho BGD; Vullo V; Lucchi NW; Severini C
    Infection; 2018 Dec; 46(6):867-870. PubMed ID: 29980936
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A randomized trial of dihydroartemisinin-piperaquine versus artemether-lumefantrine for treatment of uncomplicated Plasmodium falciparum malaria in Mali.
    Dama S; Niangaly H; Djimde M; Sagara I; Guindo CO; Zeguime A; Dara A; Djimde AA; Doumbo OK
    Malar J; 2018 Oct; 17(1):347. PubMed ID: 30290808
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment outcomes in a safety observational study of dihydroartemisinin/piperaquine (Eurartesim(®)) in the treatment of uncomplicated malaria at public health facilities in four African countries.
    Adjei A; Narh-Bana S; Amu A; Kukula V; Nagai RA; Owusu-Agyei S; Oduro A; Macete E; Abdulla S; Halidou T; Sie A; Osei I; Sevene E; Asante KP; Mulokozi A; Compaore G; Valea I; Adjuik M; Baiden R; Ogutu B; Binka F; Gyapong M
    Malar J; 2016 Jan; 15():43. PubMed ID: 26818128
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Artenimol + piperaquine. Very slow piperaquine elimination: cardiovascular risks and interactions.
    Prescrire Int; 2014 Jan; 23(145):5-8. PubMed ID: 24516901
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Paediatric formulations of artemisinin-based combination therapies for treating uncomplicated malaria in children.
    Bélard S; Ramharter M; Kurth F
    Cochrane Database Syst Rev; 2020 Dec; 12(12):CD009568. PubMed ID: 33289099
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Evaluation of the efficacy and safety of three 2-drug combinations for the treatment of uncomplicated Plasmodium falciparum malaria in Senegal: artesunate-amodiaquine, dihydroartemisinin-piperaquine, and artemether-lumefantrine].
    Sow D; Ndiaye JL; Sylla K; Ba MS; Tine RC; Faye B; Pene M; Ndiaye M; Seck A; Lo AC; Abiola A; Dieng Y; Gaye O
    Med Sante Trop; 2016; 26(1):45-50. PubMed ID: 26644184
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dihydroartemisinin-piperaquine failure associated with a triple mutant including kelch13 C580Y in Cambodia: an observational cohort study.
    Spring MD; Lin JT; Manning JE; Vanachayangkul P; Somethy S; Bun R; Se Y; Chann S; Ittiverakul M; Sia-ngam P; Kuntawunginn W; Arsanok M; Buathong N; Chaorattanakawee S; Gosi P; Ta-aksorn W; Chanarat N; Sundrakes S; Kong N; Heng TK; Nou S; Teja-isavadharm P; Pichyangkul S; Phann ST; Balasubramanian S; Juliano JJ; Meshnick SR; Chour CM; Prom S; Lanteri CA; Lon C; Saunders DL
    Lancet Infect Dis; 2015 Jun; 15(6):683-91. PubMed ID: 25877962
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Piperaquine Population Pharmacokinetics and Cardiac Safety in Cambodia.
    Vanachayangkul P; Lon C; Spring M; Sok S; Ta-Aksorn W; Kodchakorn C; Pann ST; Chann S; Ittiverakul M; Sriwichai S; Buathong N; Kuntawunginn W; So M; Youdaline T; Milner E; Wojnarski M; Lanteri C; Manning J; Prom S; Haigney M; Cantilena L; Saunders D
    Antimicrob Agents Chemother; 2017 May; 61(5):. PubMed ID: 28193647
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Piperaquine Pharmacokinetic and Pharmacodynamic Profiles in Healthy Volunteers of Papua New Guinea after Administration of Three-Monthly Doses of Dihydroartemisinin-Piperaquine.
    Millat-Martínez P; Salman S; Moore BR; Baro B; Page-Sharp M; Batty KT; Robinson LJ; Pomat W; Karunajeewa H; Laman M; Manning L; Mitjà O; Bassat Q
    Antimicrob Agents Chemother; 2022 Aug; 66(8):e0018522. PubMed ID: 35862743
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Four Artemisinin-Based Treatments in African Pregnant Women with Malaria.
    ; Pekyi D; Ampromfi AA; Tinto H; Traoré-Coulibaly M; Tahita MC; Valéa I; Mwapasa V; Kalilani-Phiri L; Kalanda G; Madanitsa M; Ravinetto R; Mutabingwa T; Gbekor P; Tagbor H; Antwi G; Menten J; De Crop M; Claeys Y; Schurmans C; Van Overmeir C; Thriemer K; Van Geertruyden JP; D'Alessandro U; Nambozi M; Mulenga M; Hachizovu S; Kabuya JB; Mulenga J
    N Engl J Med; 2016 Mar; 374(10):913-27. PubMed ID: 26962727
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.